EQUITY AND EARNINGS PER SHARE - Schedule of Warrants (Details) - Share-based Payment Arrangement, Nonemployee - Stock options and common stock purchase warrants shares in Millions |
9 Months Ended |
---|---|
Sep. 30, 2021
$ / shares
shares
| |
Number of Warrants (in millions) | |
Beginning balance (in shares) | shares | 43.4 |
Granted (in shares) | shares | 0.0 |
Exercised (in shares) | shares | 0.0 |
Expired (in shares) | shares | 0.0 |
Ending balance (in shares) | shares | 43.4 |
Weighted Average Exercise Price (per share) | |
Beginning balance (in dollars per share) | $ 6.79 |
Granted (in dollars per share) | 0 |
Exercised (in dollars per share) | 0 |
Expired (in dollars per share) | 0 |
Ending balance (in dollars per share) | 6.58 |
Warrant, exercise price, decrease (in dollars per share) | $ 0.10 |
X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price No definition available.
|
X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations in Period, Weighted Average Exercise Price No definition available.
|
X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price No definition available.
|
X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price No definition available.
|
X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|